Published October 1995 | public
Journal Article

Engineering Protein-Lipid Interactions: Targeting of Histidine-Tagged Proteins to Metal-Chelating Lipid Monolayers

An error occurred while generating the citation.

Abstract

In an effort to devise simple and robust systems that can reproduce in synthetic membranes important features of biological targeting and surface assembly, a versatile system for targeting proteins to lipid membranes has been developed. This system utilizes metal-chelating iminodiacetate (IDA) lipids loaded with divalent metal ions (Cu^(2+) or Ni^(2+)) to target proteins genetically modified with a poly(histidine) fusion peptide. The new pyrene-labeled iminodiacetate lipid 2 can be used for fluorescence imaging and spectroscopic studies of lipid reorganization induced by protein binding and assembly on lipid membranes. Metal-chelating IDA lipids 1 and 2 target the soluble domain of cytochrome b_5 to lipid assemblies by sharing the metal ion with a six-histidine sequence appended to the protein C-terminus. Protein binding to Langmuir monolayers containing the IDA-Cu^(2+) lipids 1 and 2 is observed by monitoring increases in the monolayer area at a surface pressure high enough to block nonspecific protein insertion (25 mN/m). The His-tagged cytochrome b5 binds the Cu^(2+)-loaded 2 monolayer with high affinity (K_d < 50 nM). No binding is observed in the absence of metal ions or for cytochrome b_5 without the 6-His fusion peptide. Specific protein targeting to the monolayer loaded with Ni^(2+) is confirmed by fluorescence microscopy of fluorescein-labeled 6-His cytochrome b_5. The poly(histidine) fusion peptide, widely used for recombinant protein purification, makes this targeting approach applicable to a large number of proteins.

Additional Information

© 1995 American Chemical Society. Received May 9, 1995. This research was supported by the Office of Naval Research (N00014-92-J-1178), D.W.P. is a Landau Fellow and is supported by a training fellowship from the National Institute of General Medical Sciences, NRSA Award 1 T32 GM 08346-01.

Additional details

Created:
August 20, 2023
Modified:
October 18, 2023